Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company 2021-01-29 08:29
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals 2021-01-28 22:03
Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA 2021-01-28 22:00
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil 2021-01-28 19:57
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK 2021-01-28 15:30
Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis 2021-01-28 12:54
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease 2021-01-28 09:00
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM 2021-01-28 08:00
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM 2021-01-28 08:00
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study 2021-01-27 20:00
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation 2021-01-27 11:21
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA 2021-01-27 08:26
I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer 2021-01-26 05:05
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
China Biologic Announces Extraordinary General Meeting of Shareholders 2021-01-25 21:44
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
Boehringer Ingelheim named Top Employer in Malaysia, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Vietnam, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Philippines, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Singapore, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
1 261 262 263 264 265 412